ACB
SUPN icon

Aristotle Capital Boston’s Supernus Pharmaceuticals SUPN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$25.5M Sell
808,395
-64,293
-7% -$2.03M 1.3% 25
2025
Q1
$28.6M Sell
872,688
-203,180
-19% -$6.65M 1.43% 21
2024
Q4
$38.9M Sell
1,075,868
-118,358
-10% -$4.28M 1.44% 20
2024
Q3
$37.2M Sell
1,194,226
-8,940
-0.7% -$279K 1.23% 28
2024
Q2
$32.2M Buy
1,203,166
+63,320
+6% +$1.69M 1.08% 35
2024
Q1
$38.9M Sell
1,139,846
-19,982
-2% -$682K 1.18% 29
2023
Q4
$33.6M Sell
1,159,828
-28,153
-2% -$815K 1.03% 38
2023
Q3
$32.8M Buy
1,187,981
+26,034
+2% +$718K 1.06% 35
2023
Q2
$34.9M Buy
1,161,947
+6,798
+0.6% +$204K 1.05% 34
2023
Q1
$41.9M Buy
1,155,149
+28,268
+3% +$1.02M 1.29% 20
2022
Q4
$40.2M Sell
1,126,881
-30,672
-3% -$1.09M 1.27% 22
2022
Q3
$39.2M Sell
1,157,553
-110,187
-9% -$3.73M 1.32% 15
2022
Q2
$36.7M Buy
1,267,740
+9,673
+0.8% +$280K 1.09% 26
2022
Q1
$40.7M Sell
1,258,067
-27,805
-2% -$899K 1.03% 30
2021
Q4
$37.5M Sell
1,285,872
-32,237
-2% -$940K 0.88% 43
2021
Q3
$35.2M Buy
1,318,109
+256,456
+24% +$6.84M 0.82% 48
2021
Q2
$32.7M Buy
1,061,653
+88,360
+9% +$2.72M 0.75% 54
2021
Q1
$25.5M Sell
973,293
-48,333
-5% -$1.27M 0.57% 82
2020
Q4
$25.7M Sell
1,021,626
-50,826
-5% -$1.28M 0.61% 74
2020
Q3
$22.4M Buy
1,072,452
+44,614
+4% +$930K 0.65% 63
2020
Q2
$24.4M Buy
1,027,838
+287,199
+39% +$6.82M 0.74% 50
2020
Q1
$13.3M Sell
740,639
-16,864
-2% -$303K 0.57% 72
2019
Q4
$18M Buy
757,503
+13,511
+2% +$320K 0.5% 88
2019
Q3
$20.4M Buy
743,992
+639,961
+615% +$17.6M 0.6% 72
2019
Q2
$3.44M Buy
+104,031
New +$3.44M 0.11% 123